315 related articles for article (PubMed ID: 28965860)
1. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860
[TBL] [Abstract][Full Text] [Related]
2. Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence.
El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
J Control Release; 2018 Aug; 283():32-44. PubMed ID: 29792888
[TBL] [Abstract][Full Text] [Related]
3. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
[TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats.
Chen SW; Chen YX; Zhang XR; Qian H; Chen WZ; Xie WF
Gene Ther; 2008 Nov; 15(21):1424-35. PubMed ID: 18509379
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
6. The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis.
Elshal M; Abu-Elsaad N; El-Karef A; Ibrahim TM
Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1293-304. PubMed ID: 26269412
[TBL] [Abstract][Full Text] [Related]
7. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells.
Li Q; Yan Z; Li F; Lu W; Wang J; Guo C
Nanotechnology; 2012 Jul; 23(26):265101. PubMed ID: 22700686
[TBL] [Abstract][Full Text] [Related]
8. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate.
Kim Y; Fiel MI; Albanis E; Chou HI; Zhang W; Khitrov G; Friedman SL
Liver Int; 2012 Jul; 32(6):1008-17. PubMed ID: 22507133
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
11. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
12. Oral targeted delivery of Imatinib by pH responsive copolymer modulates liver fibrosis in the mice model.
Siapoush S; Mousazadeh H; Rezaei R; Hatami B; Mazhari S; Hashemi N; Reza Zali M; Baghaei K
Int J Pharm; 2023 Jun; 641():123068. PubMed ID: 37225027
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.
Yoshiji H; Kuriyama S; Noguchi R; Ikenaka Y; Yoshii J; Yanase K; Namisaki T; Kitade M; Yamazaki M; Asada K; Akahane T; Tsujimoto T; Uemura M; Fukui H
Int J Mol Med; 2006 May; 17(5):899-904. PubMed ID: 16596278
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells.
Zhang L; Tao M; Zhang H; Zhang S; Hou X; Zong C; Sun G; Feng S; Yan H; Lu Y; Yang X; Wei L; Zhang L
Chem Biol Interact; 2024 May; 395():111015. PubMed ID: 38663797
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
[TBL] [Abstract][Full Text] [Related]
16. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.
Shiha GE; Abu-Elsaad NM; Zalata KR; Ibrahim TM
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):788-97. PubMed ID: 25115651
[TBL] [Abstract][Full Text] [Related]
17. Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.
Zhang X; Zhang F; Kong D; Wu X; Lian N; Chen L; Lu Y; Zheng S
FEBS J; 2014 Jun; 281(12):2754-68. PubMed ID: 24725506
[TBL] [Abstract][Full Text] [Related]
18. Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice.
Jiang Y; Zhao Y; He F; Wang H
Hum Gene Ther; 2019 Feb; 30(2):179-196. PubMed ID: 30024280
[TBL] [Abstract][Full Text] [Related]
19. Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL-6 pathway through miR-124.
Alavifard H; Mazhari S; Meyfour A; Tokhanbigli S; Ghavami S; Zali MR; Aghdaei HA; Hatami B; Baghaei K
Cell Biol Int; 2023 May; 47(5):969-980. PubMed ID: 36655489
[TBL] [Abstract][Full Text] [Related]
20. Targeted truncated TGF-β receptor type II delivery to fibrotic liver by PDGFβ receptor-binding peptide modification for improving the anti-fibrotic activity against hepatic fibrosis in vitro and in vivo.
Huang Z; Ding M; Dong Y; Ma M; Song X; Liu Y; Gao Z; Guan H; Chu Y; Feng H; Wang X; Liu H
Int J Biol Macromol; 2021 Oct; 188():941-949. PubMed ID: 34389395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
